Lobsters hold the secret of a long, cancer-free life in their genes
The American lobster — easily recognizable by its two hefty claws — can reach the impressive age of 100 years. The remarkable longevity is accompanied by very few signs of aging; it continuously throughout its life and does not suffer from age-related diseases such as . This exceptional resilience has garnered interest from researchers that are curious to decipher the reasons behind the lobster’s longevity and good health.

Could the genome of the American lobster provide clues about their healthy aging? Researchers at the Gloucester Marine Genomics Institute have the first draft of the American lobster genome, which revealed surprising, first insights into the animal’s unique resilience mechanisms. Their work was published in the journal Science Advances.
The researchers found genes encoding for a novel class of proteins that combine both neuronal and immune-related functions. By coupling the neural and immune system, the lobster could fight off pathogens more efficiently.
The researchers also surveyed the lobster genome for genes involved in safeguarding the genome. These safeguards prevent genomic alterations and mutations, which is crucial for and warding off . The researchers found that the American lobster has an extended repertoire of genes encoding for proteins that silence certain regions of the genome. These regions to prevent potentially disease-causing mutations such as chromosomal rearrangements. By ensuring that these regions remain silenced, the American lobster safeguards its genome throughout its long life.
With the newly deciphered lobster genome as a starting point, future research will provide further insight into the healthy aging strategies of the American lobster. More than a mere delicacy, the humble lobster could teach us a lot about healthy aging.
This story on , an editorial partner site that publishes science stories by scientists. to get even more science sent straight to you.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.

Glow-based assay sheds light on disease-causing mutations
University of Michigan researchers create a way to screen protein structure changes caused by mutations that may lead to new rare disease therapeutics.

How signals shape DNA via gene regulation
A new chromatin isolation technique reveals how signaling pathways reshape DNA-bound proteins, offering insight into potential targets for precision therapies. Read more about this recent ɬŔď·¬ paper.